National Coverage Determination
CMS Issues National Coverage Determination for the Paradise® System for Uncontrolled Hypertension
Expanding Access to Care
On October 28, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination (NCD) for renal denervation (RDN) therapy, including Recor Medical’s Paradise Ultrasound Renal Denervation System under the CMS-approved RADIANCE CED Study.
This is a major milestone for patients and providers, opening the door for broader access to the Paradise System. The NCD is a formal CMS decision establishing coverage for Medicare beneficiaries, with specific requirements for patients, facilities, and physicians.
Patient Coverage Criteria
Coverage applies to all Medicare fee-for-service and Medicare Advantage patients.
- Medicare fee-for-service and Medicare Advantage procedures must meet all the criteria outlined in the NCD to qualify for reimbursement.
- Uncontrolled hypertension SBP ≥140 mmHg & DBP ≥90 mmHg despite active clinical management
- Diagnosis confirmed via ambulatory BP monitoring or serial home BP readings
- On stable, maximally tolerated GDMT for ≥6 weeks
- Secondary hypertension evaluated and treated if appropriate
- No RDN contraindications consistent with the FDA labeling of the device used
- Coordination managed by primary clinician ≥6 months with at least 3 visits, of which 2 can be virtual
- No prior RDN procedure
See the full policy including physician and facility criteria here.
Questions About the NCD?
For additional information read Recor Medical’s press release “CMS Issues National Coverage Determination for Recor Medical’s Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension.”
Transitional Pass-through (TPT) payment
TPT payment by CMS provides an incremental payment for new technologies in the hospital outpatient setting
Paradise Ultrasound RDN System NCD Clinical Checklist
Get a copy of the Paradise Ultrasound RDN System Clinical Checklist. The clinical information highlighted in this checklist is derived from CMS’ National Coverage Determination for Renal Denervation for Uncontrolled Hypertension, and help physician gather information in connection with an HTN diagnosis.
NCD Resources
Learn more about reimbursement for Ultrasound Renal Denervation
Paradise Ultrasound RDN Reimbursement Support
To facilitate patient access, our dedicated team can assist you with education on, and submission of, prior authorizations and appeals for the Paradise uRDN procedure. If you are a healthcare provider and would like additional information or assistance, reach out to our reimbursement team.